Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/14/2010 | WO2010053621A2 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof |
05/14/2010 | WO2010053587A2 Methods of monitoring conditions by sequence analysis |
05/14/2010 | WO2010053539A2 Methods for detecting colorectal diseases and disorders |
05/14/2010 | WO2010053518A2 Methods and compositions for inactivating glutamine synthetase gene expression |
05/14/2010 | WO2010053508A1 Generation of patient-specific differentiated cell types by epigenetic induction |
05/14/2010 | WO2010053435A2 Compounds and methods for the treatment of inflammatory diseases of the cns |
05/14/2010 | WO2010053433A1 Increased expression of specific antigens |
05/14/2010 | WO2010053430A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
05/14/2010 | WO2010053199A1 Pharmaceutical composition for treating prostate cancer, and method for treating prostate cancer |
05/14/2010 | WO2010053161A1 Modified flavin-adenine-dinucleotide-dependent glucose dehydrogenase |
05/14/2010 | WO2010053077A1 Process for producing menaquinone-4 |
05/14/2010 | WO2010053052A1 Bacterium capable of producing 2-deoxy-scyllo-inosose (doi), and process for producing 2-deoxy-scyllo-inosose (doi) by using same |
05/14/2010 | WO2010052904A1 Method for producing neural stem cells |
05/14/2010 | WO2010052326A1 Small interfering rna delivery |
05/14/2010 | WO2010052319A1 Improved production of riboflavin |
05/14/2010 | WO2010052288A1 Teneurin and cancer |
05/14/2010 | WO2010052229A1 Hla-g polypeptides and pharmaceutical uses thereof |
05/14/2010 | WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof |
05/14/2010 | WO2010051649A1 Systems and methods for enhanced scoda |
05/14/2010 | WO2010051643A1 Transfection with magnetic nanoparticles and ultrasound |
05/14/2010 | WO2010051639A1 Use of mir-126 for enhancing hematopoietic stem cell engraftment, for isolating hematopoietic stem cells, and for treating and monitoring the treatment of acute myeloid leukemia |
05/14/2010 | WO2010051632A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
05/14/2010 | WO2010036771A3 Herbicide-resistant ahas-mutants and methods of use |
05/14/2010 | WO2010033798A3 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment |
05/14/2010 | WO2010032230A9 Non-auxotrophic selection marker |
05/14/2010 | WO2010027710A3 Ketoreductase polypeptides and uses thereof |
05/14/2010 | WO2010025936A9 Method for producing eukaryotic organisms with enhanced pathogen resistance and/or resistance to stress and eukaryotic transgenic organisms with enhanced pathogen resistance and/or resistance to stress |
05/14/2010 | WO2010025016A3 Enhancement of transgene expression from virus-based vaccine vectors using suppressors of the type 1 interferon response |
05/14/2010 | WO2010023544A4 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction |
05/14/2010 | WO2010022740A3 Hiv-1 envelope polypeptides for hiv vaccine |
05/14/2010 | WO2010020654A3 Plants with increased yield by increasing or generating one or more activities in a plant or a part thereof |
05/14/2010 | WO2010019571A3 A novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis |
05/14/2010 | WO2010018444A3 An expression vector and a method thereof |
05/14/2010 | WO2010017264A3 Photo-crosslinked nucleic acid hydrogels |
05/14/2010 | WO2010014631A3 Methods and compositions for improving the production of products in microorganisms |
05/14/2010 | WO2010014218A3 Puf-a and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders |
05/14/2010 | WO2010011283A3 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases |
05/14/2010 | WO2010009348A3 Transformation of glycerol and cellulosic materials into high energy fuels |
05/14/2010 | WO2010003153A3 Methylation analysis of mate pairs |
05/14/2010 | WO2009155601A3 Processing cellulosic biomass |
05/14/2010 | WO2009143035A3 Methods and compositions for diagnosing and treating cervical intraepithelial neoplasia and cervical cancer |
05/14/2010 | WO2009141407A3 A method for the production of medium-chain sophorolipids |
05/14/2010 | CA2778961A1 Compounds and methods for the treatment of inflammatory diseases of the cns |
05/14/2010 | CA2778938A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
05/14/2010 | CA2743122A1 Fully human antibodies against n-cadherin |
05/14/2010 | CA2743057A1 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling |
05/14/2010 | CA2743049A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
05/14/2010 | CA2742969A1 Anti-dll4 antibodies and uses thereof |
05/14/2010 | CA2742861A1 Engineered antibodies with reduced immunogenicity and methods of making |
05/14/2010 | CA2742710A1 Crhr2 peptide agonists and uses thereof |
05/14/2010 | CA2742598A1 Nucleic acid extraction on curved glass surfaces |
05/14/2010 | CA2742597A1 Modulation of toll-like receptor 4 expression by antisense oligonucleotides |
05/14/2010 | CA2742596A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides |
05/14/2010 | CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides |
05/14/2010 | CA2742521A1 Hla-g polypeptides and pharmaceutical uses thereof |
05/14/2010 | CA2742517A1 Hla-g proteins and pharmaceutical uses thereof |
05/14/2010 | CA2742460A1 Systems and methods for enhanced scoda |
05/14/2010 | CA2742281A1 Immunosuppression compound and treatment method |
05/14/2010 | CA2742278A1 Temperature-induced polynucleotides and uses therefor |
05/14/2010 | CA2742151A1 Transfection with magnetic nanoparticles and ultrasound |
05/14/2010 | CA2741996A1 Sequence preserved dna conversion |
05/14/2010 | CA2741119A1 Methods and compositions for inactivating glutamine synthetase gene expression |
05/14/2010 | CA2741045A1 Novel at1g67330 gene involved in altered nitrate uptake efficiency |
05/14/2010 | CA2736486A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof |
05/14/2010 | CA2727520A1 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
05/13/2010 | US20100122382 Cell Cycle Genes and Related Methods |
05/13/2010 | US20100122381 Nucleic acid molecules and other molecules associated with plants |
05/13/2010 | US20100122380 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
05/13/2010 | US20100122378 Truncated alternan sucrase coding nucleic acid molecules |
05/13/2010 | US20100122376 Methods of enhancing the resistance of plants to bacterial pathogens |
05/13/2010 | US20100122375 Compositions and methods for enhancing disease resistance in plants |
05/13/2010 | US20100122374 Disease resistance in plants by introducing transcription factor gene |
05/13/2010 | US20100122373 Nucleic acid molecules and other molecules associated with plants |
05/13/2010 | US20100122369 Switchgrass Cultivar EG1102 |
05/13/2010 | US20100122368 Switchgrass Cultivar EG1101 |
05/13/2010 | US20100122367 Dominant Gene Suppression Transgenes and Methods of Using Same |
05/13/2010 | US20100122366 Development of controlled total vegetative growth for prevention of transgene escape from genetically modified plants and for enhancing biomass production |
05/13/2010 | US20100122365 Optimizing glycan processing in plants |
05/13/2010 | US20100122364 Method of constructing nucleus-implanted egg, parthenogenetic embryo and parthenogenetic mammal |
05/13/2010 | US20100122361 Humanisation of animals |
05/13/2010 | US20100122358 H-Chain-only antibodies |
05/13/2010 | US20100122357 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies |
05/13/2010 | US20100122356 Pig model for psoriasis |
05/13/2010 | US20100121135 Sperm cell separation methods and compositions |
05/13/2010 | US20100121044 Solid phase technique for selectively isolating nucleic acids |
05/13/2010 | US20100121043 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-CROSS-LINKED POLYMERIC MICELLE |
05/13/2010 | US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds |
05/13/2010 | US20100120897 Novel helper plasmid, defective sindbis viral vectors and methods of use thereof |
05/13/2010 | US20100120895 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
05/13/2010 | US20100120894 Intracellular DNA receptor |
05/13/2010 | US20100120893 Compositions and Methods for Inhibiting Expression of Transthyretin |
05/13/2010 | US20100120892 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
05/13/2010 | US20100120891 Use of a galectin-1-targeted rnai-based approach for the treatment of cancer |
05/13/2010 | US20100120701 Compositions and Methods For Engineering Probiotic Yeast |
05/13/2010 | US20100120690 Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same |
05/13/2010 | US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof |
05/13/2010 | US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy |
05/13/2010 | US20100120677 Activity of recombinant equine follicle stimulating hormone |
05/13/2010 | US20100120675 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
05/13/2010 | US20100120665 Treatment of diseases characterized by inflammation |